| Literature DB >> 28576415 |
Nicholas Liang1, Cleber A Trujillo1, Priscilla D Negraes1, Alysson R Muotri1, Claudiana Lameu2, Henning Ulrich3.
Abstract
Human induced pluripotent stem cells (iPSCs) represent a revolutionary tool for disease modeling and drug discovery. The generation of tissue-relevant cell types exhibiting a patient's genetic and molecular background offers the ability to develop individual and effective therapies. In this review, we present some major achievements in the neuroscience field using iPSCs and discuss promising perspectives in personalized medicine. In addition to disease modeling, the understanding of the cellular and molecular basis of neurological disorders is explored, including the discovery of new targets and potential drugs. Ultimately, we highlight how iPSC technology, together with genome editing approaches, may bring a deep impact on pre-clinical trials by reducing costs and increasing the success of treatments in a personalized fashion.Entities:
Keywords: Disease modeling; Drug screening; Neurological disorders; iPSC
Mesh:
Year: 2017 PMID: 28576415 DOI: 10.1016/j.pnpbp.2017.05.025
Source DB: PubMed Journal: Prog Neuropsychopharmacol Biol Psychiatry ISSN: 0278-5846 Impact factor: 5.067